Dr NEIL NIXON's Outputs (2)

Mindfulness-Based Cognitive Therapy-for Life (MBCT-L) versus Stress-Reduction Psychoeducation (SRP) for the improvement of mental wellbeing in healthcare and other public sector staff: Protocol for the ‘Well at Work’ randomised controlled trial (2025)
Journal Article
Nixon, E., Patel, S., Patel, P., Roe, J., Nixon, N., Sweeney, T., Bernard, P., Strauss, C., Craven, M., Malins, S., Goodwin, R., Astill Wright, L., Guo, B., & Morriss, R. (in press). Mindfulness-Based Cognitive Therapy-for Life (MBCT-L) versus Stress-Reduction Psychoeducation (SRP) for the improvement of mental wellbeing in healthcare and other public sector staff: Protocol for the ‘Well at Work’ randomised controlled trial. JMIR Research Protocols, https://doi.org/10.2196/67695

Background:

Recently published guidelines by the National Institute for Health and Care Excellence (NICE) have recommended both mindfulness-based and stress-reduction approaches as effective preventative mental wellbeing interventions for healthca... Read More about Mindfulness-Based Cognitive Therapy-for Life (MBCT-L) versus Stress-Reduction Psychoeducation (SRP) for the improvement of mental wellbeing in healthcare and other public sector staff: Protocol for the ‘Well at Work’ randomised controlled trial.

A randomised controlled trial investigating the clinical and cost-effectiveness of Alpha-Stim AID cranial electrotherapy stimulation (CES) in patients seeking treatment for moderate severity depression in primary care (Alpha-Stim-D Trial) (2022)
Journal Article
Patel, S., Boutry, C., Patel, P., Craven, M. P., Guo, B., Zafar, A., Kai, J., Smart, D., Butler, D., Higton, F., McNaughton, R., Briley, P. M., Griffiths, C., Nixon, N., Sayal, K., & Morriss, R. (2022). A randomised controlled trial investigating the clinical and cost-effectiveness of Alpha-Stim AID cranial electrotherapy stimulation (CES) in patients seeking treatment for moderate severity depression in primary care (Alpha-Stim-D Trial). Trials, 23(1), Article 250. https://doi.org/10.1186/s13063-022-06192-1

Background: Major depression is the second leading cause of years lost to disability worldwide and is a leading contributor to suicide. However, first-line antidepressants are only fully effective for 33%, and only 40% of those offered psychological... Read More about A randomised controlled trial investigating the clinical and cost-effectiveness of Alpha-Stim AID cranial electrotherapy stimulation (CES) in patients seeking treatment for moderate severity depression in primary care (Alpha-Stim-D Trial).